Control Individuals | Patients with Vasculogenic ED | ||
---|---|---|---|
% | |||
No l-NOARG (100 μM) | |||
+ ACh (1 μM) | 53 ± 8 (14) | 81 ± 6 (8)* | |
+ ACh (10 μM) | 43 ± 6 (13) | 67 ± 5 (8)* | |
With l-NOARG (100 μM) | |||
+ ACh (1 μM) | 92 ± 2 (5)* | N.T. | |
+ ACh (10 μM) | 77 ± 6 (5)* | N.T. |
N.T., not tested
↵* P < 0.05 compared with the effect of ACh in control subjects in the absence of l-NOARG